Deal snapshot: LumiThera Acquires Assets of Diagnostic Tool Developer MacuLogix.

MANews-(C)2009-2022

A wholly owned subsidiary of Washington, US-based medical device company LumiThera Inc. has acquired assets of Pennsylvania, US-based MacuLogix, Inc., offering early diagnosis of dry age-related macular degeneration, the company said.

Terms of the transaction were not disclosed. MacuLogix, Inc. is the developer of the wearable AdaptDX Pro dark adaptometer. LumiThera is a...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT